(Q34689061)

English

Decreased FOXF2 mRNA expression indicates early-onset metastasis and poor prognosis for breast cancer patients with histological grade II tumor

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Decreased FOXF2 mRNA expression indicates early-onset metastasis and poor prognosis for breast cancer patients with histological grade II tumor (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

author name string

Peng-Zhou Kong

1

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Fan Yang

2

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Lin Li

3

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Xiao-Qing Li

4

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Yu-Mei Feng

5

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

language of work or name

0 references

publication date

19 April 2013

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

e61591

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

copyright license

Creative Commons Attribution 4.0 International

19 April 2013

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

GOBO: gene expression-based outcome for breast cancer online

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3631231

7 July 2018

MicroRNA-301 mediates proliferation and invasion in human breast cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3631231

7 July 2018

Triple-Negative Breast Cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3631231

7 July 2018

Epigenetic inactivation of the potential tumor suppressor gene FOXF1 in breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3631231

7 July 2018

FOXC1 is a potential prognostic biomarker with functional significance in basal-like breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3631231

7 July 2018

The Fox genes in the liver: from organogenesis to functional integration

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3631231

7 July 2018

The evolution of Fox genes and their role in development and disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3631231

7 July 2018

Gene expression of forkhead transcription factors in the normal and diseased human prostate

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3631231

7 July 2018

Oestrogen-receptor-positive breast cancer: towards bridging histopathological and molecular classifications.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3631231

7 July 2018

The CD44+/CD24- phenotype is enriched in basal-like breast tumors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3631231

7 July 2018

Gene expression profiling and histopathological characterization of triple-negative/basal-like breast carcinomas

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3631231

7 July 2018

Mesenchyme Forkhead 1 (FOXC2) plays a key role in metastasis and is associated with aggressive basal-like breast cancers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3631231

7 July 2018

Increased expression of urokinase-type plasminogen activator mRNA determines adverse prognosis in ErbB2-positive primary breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3631231

7 July 2018

Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3631231

7 July 2018

Foxf1 and Foxf2 control murine gut development by limiting mesenchymal Wnt signaling and promoting extracellular matrix production

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3631231

7 July 2018

Gene expression profiling spares early breast cancer patients from adjuvant therapy: derived and validated in two population-based cohorts

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3631231

7 July 2018

An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3631231

7 July 2018

Oestrogen receptor status, pathological complete response and prognosis in patients receiving neoadjuvant chemotherapy for early breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3631231

7 July 2018

Human FOX gene family (Review)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3631231

7 July 2018

Breast cancer classification and prognosis based on gene expression profiles from a population-based study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3631231

7 July 2018

Repeated observation of breast tumor subtypes in independent gene expression data sets

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3631231

7 July 2018

Gene expression profiles of human breast cancer progression

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3631231

7 July 2018

Forkhead transcription factors: key players in development and metabolism

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3631231

7 July 2018

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3631231

7 July 2018

Prognostic role of clinical, pathological and biological characteristics in patients with locally advanced breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3631231

7 July 2018

Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3631231

7 July 2018

HER-2 as a target for breast cancer therapy.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0061591

21 January 2018

Triple-negative breast cancer: distinguishing between basal and nonbasal subtypes

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0061591

21 January 2018

Forkhead box A1 expression in breast cancer is associated with luminal subtype and good prognosis.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0061591

21 January 2018

Forkhead transcription factor Foxf2 (LUN)-deficient mice exhibit abnormal development of secondary palate.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0061591

21 January 2018

Forkhead transcription factor FoxF2 is expressed in mesodermal tissues involved in epithelio-mesenchymal interactions.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0061591

21 January 2018

Strong time dependence of the 76-gene prognostic signature for node-negative breast cancer patients in the TRANSBIG multicenter independent validation series

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0061591

21 January 2018

Endocrine therapy of breast cancer

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3631231

26 October 2018

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0061591

21 January 2018

Biological Processes Associated with Breast Cancer Clinical Outcome Depend on the Molecular Subtypes

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0061591

21 January 2018

The FOXF2 pathway in the human prostate stroma

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0061591

21 January 2018

The CD44+/CD24- phenotype relates to 'triple-negative' state and unfavorable prognosis in breast cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/23620774

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Differences in the embryonic expression patterns of mouse Foxf1 and -2 match their distinct mutant phenotypes

1 reference

https://pubmed.ncbi.nlm.nih.gov/23620774

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

FOXA1: Growth inhibitor and a favorable prognostic factor in human breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/23620774

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Differentially expressed genes between primary cancer and paired lymph node metastases predict clinical outcome of node-positive breast cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/23620774

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

FOXA1 Expression in Breast Cancer Correlation with Luminal Subtype A and Survival

1 reference

https://pubmed.ncbi.nlm.nih.gov/23620774

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1371/JOURNAL.PONE.0061591

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

2013PLoSO...861591K

0 references

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34689061&oldid=1865016047"